Literature DB >> 10614679

Diagnosis and pathogenesis of glaucomatous optic neuropathy: morphological aspects.

J B Jonas1, W M Budde.   

Abstract

Glaucomatous optic neuropathy is classified by morphologic changes in the intrapapillary and parapapillary region of the optic nerve head and the retinal nerve fibre layer. These changes can be evaluated using descriptive optic nerve head variables which are the size and shape of the optic disc; size, shape and pallor of the neuroretinal rim; size of the optic cup in relation to the area of the disc; configuration and depth of the optic cup; cup-to-disc diameter ratio and cup-to-disc area ratio; position of the exit of the central retinal vessel trunk on the lamina cribrosa surface; presence and location of splinter-shaped haemorrhages; occurrence, size, configuration and location of parapapillary chorioretinal atrophy; diffuse and/or focal decrease of the diameter of the retinal arterioles; and visibility of the retinal nerve fibre layer. Assessment of these variables is useful for the early detection of glaucomatous optic nerve damage, to follow-up patients with glaucoma, to differentiate various types of the chronic open-angle glaucomas, and to get hints for the pathogenesis of glaucomatous optic nerve fibre loss.

Entities:  

Mesh:

Year:  2000        PMID: 10614679     DOI: 10.1016/s1350-9462(99)00002-6

Source DB:  PubMed          Journal:  Prog Retin Eye Res        ISSN: 1350-9462            Impact factor:   21.198


  38 in total

1.  Optic nerve oxygen tension: the effects of timolol and dorzolamide.

Authors:  J F Kiilgaard; D B Pedersen; T Eysteinsson; M la Cour; K Bang; P K Jensen; E Stefánsson
Journal:  Br J Ophthalmol       Date:  2004-02       Impact factor: 4.638

2.  Relationships between visual field sensitivity and spectral absorption properties of the neuroretinal rim in glaucoma by multispectral imaging.

Authors:  Jonathan Denniss; Ingo Schiessl; Vincent Nourrit; Cecilia H Fenerty; Ramesh Gautam; David B Henson
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-07       Impact factor: 4.799

3.  [Medicinal glaucoma therapy. What can we learn from large randomized clinical trials?].

Authors:  A G M Jünemann; C Huchzermeyer; R Rejdak
Journal:  Ophthalmologe       Date:  2013-12       Impact factor: 1.059

4.  Optic disc size in a population based study in northern China: the Beijing Eye Study.

Authors:  Y Wang; L Xu; L Zhang; H Yang; Y Ma; J B Jonas
Journal:  Br J Ophthalmol       Date:  2006-03       Impact factor: 4.638

5.  RetCam image analysis of the optic disc in premature infants.

Authors:  J W Park; S W Park; H Heo
Journal:  Eye (Lond)       Date:  2013-07-12       Impact factor: 3.775

6.  The microbead occlusion model: a paradigm for induced ocular hypertension in rats and mice.

Authors:  Rebecca M Sappington; Brian J Carlson; Samuel D Crish; David J Calkins
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-10-22       Impact factor: 4.799

7.  Vaccination for neuroprotection in the mouse optic nerve: implications for optic neuropathies.

Authors:  J Fisher; H Levkovitch-Verbin; H Schori; E Yoles; O Butovsky; J F Kaye; A Ben-Nun; M Schwartz
Journal:  J Neurosci       Date:  2001-01-01       Impact factor: 6.167

8.  Characterizing the Collagen Network Structure and Pressure-Induced Strains of the Human Lamina Cribrosa.

Authors:  Yik Tung Tracy Ling; Ran Shi; Dan E Midgett; Joan L Jefferys; Harry A Quigley; Thao D Nguyen
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-06-03       Impact factor: 4.799

9.  The ISNT Rule: How Often Does It Apply to Disc Photographs and Retinal Nerve Fiber Layer Measurements in the Normal Population?

Authors:  Linda Yi-Chieh Poon; David Solá-Del Valle; Angela V Turalba; Iryna A Falkenstein; Michael Horsley; Julie H Kim; Brian J Song; Hana L Takusagawa; Kaidi Wang; Teresa C Chen
Journal:  Am J Ophthalmol       Date:  2017-09-23       Impact factor: 5.258

10.  TRPV1: contribution to retinal ganglion cell apoptosis and increased intracellular Ca2+ with exposure to hydrostatic pressure.

Authors:  Rebecca M Sappington; Tatiana Sidorova; Daniel J Long; David J Calkins
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-10-24       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.